Quince Therapeutics (QNCX) Earnings Date, Estimates & Call Transcripts $1.06 -0.04 (-3.21%) As of 02:38 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Quince Therapeutics Earnings Summary Upcoming Earnings DateMay. 12Before Market OpensEstimatedConsensus EPS (Mar. 24) -$0.19 Actual EPS (Mar. 24) -$0.28 Missed By -$0.09 Actual Revenue (Mar. 24) $0.17MQuince Therapeutics released Q4 2024 earnings on March 24, 2025, reporting an EPS of -$0.28, which missed the consensus estimate of -$0.19 by $0.09. Quarterly revenue was reported to be $0.17 million. With a trailing EPS of -$1.31, Quince Therapeutics' earnings are expected to grow next year, from ($1.21) to ($0.79) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K) Press Release (8-K)QNCX Upcoming EarningsQuince Therapeutics' Q1 2025 earnings is scheduled for Monday, May 12, 2025, with a conference call scheduled on Sunday, May 11, 2025 at 6:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Quince Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Quince Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataQNCX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Quince Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($1.21) EPSNext Year EPS Consensus Estimate ($0.79) EPS Quince Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/12/2025(Estimated)--------3/24/2025Q4 2024-$0.19-$0.28 -$0.09-$0.28-$0.17M8/13/2024Q2 2024--$0.18 -$0.18$0.28--5/13/2024Q1 2024--$0.26 -$0.26-$0.26--4/1/2024Q4 2023--$0.21 -$0.21-$0.21--11/14/2023Q3 2023--$0.15 -$0.15-$0.15--8/3/2023Q2 2023--$0.14 -$0.14-$0.14--5/15/2023Q1 2023--$0.34 -$0.34-$0.34-- Quince Therapeutics Earnings - Frequently Asked Questions When is Quince Therapeutics's earnings date? Quince Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based off last year's report dates. Learn more on QNCX's earnings history. Did Quince Therapeutics beat their earnings estimates last quarter? In the previous quarter, Quince Therapeutics (NASDAQ:QNCX) missed the analysts' consensus estimate of ($0.19) by $0.09 with a reported earnings per share (EPS) of ($0.28). Learn more on analysts' earnings estimate vs. QNCX's actual earnings. How much profit does Quince Therapeutics generate each year? Quince Therapeutics (NASDAQ:QNCX) has a recorded net income of -$31.39 million. QNCX has generated -$1.31 earnings per share over the last four quarters. What is Quince Therapeutics's EPS forecast for next year? Quince Therapeutics's earnings are expected to grow from ($1.21) per share to ($0.79) per share in the next year. More Earnings Resources from MarketBeat Related Companies GOSS Earnings DMAC Earnings MDWD Earnings ELDN Earnings CRDF Earnings VYGR Earnings ALMS Earnings FULC Earnings YMAB Earnings BTMD Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Palantir Stock Drops Despite Stellar Earnings: What's Next?Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?Warning or Opportunity After Super Micro Computer's EarningsAmazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2 This page (NASDAQ:QNCX) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quince Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quince Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy QNCX Stock Free QNCX Stock Alerts